TCI Wealth Advisors’s Integra LifeSciences IART Stock Holding History

TCI Wealth Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37	Closed	-$2.13K	–	1122
2023 Q1	$2.13K	Hold	37	–	–	﹤0.01%	1952
2022 Q4	$2.08K	Buy	37 +1	+3%	+$51	﹤0.01%	1967
2022 Q3	$2K	Sell	36 -35	-49%	-$1.79K	﹤0.01%	1939
2022 Q2	$4K	Hold	71	–	–	﹤0.01%	1628
2022 Q1	$5K	Hold	71	–	–	﹤0.01%	1550
2021 Q4	$5K	Hold	71	–	–	﹤0.01%	1659
2021 Q3	$5K	Hold	71	–	–	﹤0.01%	1598
2021 Q2	$5K	Hold	71	–	–	﹤0.01%	1446
2021 Q1	$5K	Hold	71	–	–	﹤0.01%	1263
2020 Q4	$5K	Buy	71 +39	+122%	+$2.1K	﹤0.01%	872
2020 Q3	$2K	Buy	+32	New	+$1.52K	﹤0.01%	1119
2020 Q1	–	Sell	-36	Closed	-$2K	–	1601
2019 Q4	$2K	Buy	+36	New	+$2.14K	﹤0.01%	1154

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's IART Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 37 shares — an estimated $2.13K sold.

TCI Wealth Advisors first reported a position in IART in Q4 2019 and held it in 12 quarters. The position peaked at $5K in Q1 2022. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

TCI Wealth Advisors reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 37 Integra LifeSciences shares in Q2 2023, an estimated $2.13K.
TCI Wealth Advisors first reported a position in Integra LifeSciences in Q4 2019 and held it in 12 quarters.
TCI Wealth Advisors's Integra LifeSciences position peaked at $5K in Q1 2022.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.